Dendritic cell therapies in transplantation revisited: Deletion of recipient DCs deters the effect of therapeutic DCs

American Journal of Transplantation

Volumn 12, Issue 6, 2012, Pages 1398-1408

  Wang, Z ^a,b,d   Divito, S J ^a   Shufesky, W J ^a   Sumpter, T ^c   Wang, H ^b   Tkacheva, O A ^c   Wang, W ^b,d   Liu, C ^b,e   Larregina, A T ^c   Morelli, A E ^a,c  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d THE SECOND AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^e Tianhe Hospital   (China)

Author keywords

dendritic cell therapies; Dendritic cells; immunosuppression; tolerance; transplantation

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; CELL SPECIFICITY; CELL THERAPY; CONTROLLED STUDY; DENDRITIC CELL THERAPY; EX VIVO STUDY; GRAFT RECIPIENT; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADOPTIVE TRANSFER; ANIMALS; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNOSUPPRESSIVE AGENTS; MICE; MICE, INBRED STRAINS; TRANSPLANTATION;

EID: 84861829497     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2012.04060.x     Document Type: Article

References (48)

1. Morelli AE, Thomson AW,. Tolerogenic dendritic cells and the quest for transplant tolerance. Nat Rev Immunol 2007; 7: 610-621.
2. Fu F, Li Y, Qian S, et al,. Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80 dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients. Transplantation 1996; 62: 659-665.
3. Lu L, Li W, Fu F, et al,. Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival. Transplantation 1997; 64: 1808-1815.
4. Lutz MB, Suri RM, Niimi M, et al,. Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo. Eur J Immunol 2000; 30: 1813-1822.
5. Min WP, Gorczynski R, Huang X-Y, et al,. Dendritic cells genetically engineered to express Fas ligand induce donor-specific hyporesponsiveness and prolong allograft survival. J Immunol 2000; 164: 161-167.
6. Bonham CA, Peng L, Liang X, et al,. Marked prolongation of cardiac allograft survival by dendritic cells genetically engineered with NF-κB oligodeoxyribonucleotide decoys and adenoviral vectors encoding CTLA-Ig. J. Immunol 2002; 169: 3382-3391.
7. DePaz HA, Oluwole OO, Adeyeri AO, et al,. Immature rat myeloid dendritic cells generated in low-dose granulocyte macrophage-colony stimulating factor prolong donor-specific rat cardiac allograft survival. Transplantation 2003; 75: 521-528.
8. Lan YY, Wang Z, Raimondi G, et al,. "Alternatively activated" dendritic cells preferentially secrete IL-10, expand Foxp3+CD4+ T cells, and induce long-term organ allograft survival in combination with CTLA4-Ig. J Immunol 2006; 177: 5868-5877.
9. Emmer PM, van der Vlag J, Adema GJ, Hilbrands LB,. Dendritic cells activated by lipopolysaccharide after dexamethasone treatment induce donor-specific allograft hyporesponsiveness. Transplantation 2006; 81: 1451-1459.
10. Zhang X, Li M, Lian D, et al,. Generation of therapeutic dendritic cells and regulatory T cells for preventing allogeneic cardiac graft rejection. Clin Immunol 2008; 127: 313-321.
11. Garovillo M, Ayoola A, Depaz HA, et al,. Induction of transplant tolerance with immunodominant allopeptide-pulsed host lymphoid and myeloid dendritic cells. Am J Transplant 2001; 1: 129-137.
12. Taner T, Hackstein H, Wang Z, Morelli AE, Thomson AW,. Rapamycin-treated, alloantigen-pulsed host dendritic cells induce Ag-specific T cell regulation and prolong graft survival. Am J Transplant 2005; 5: 228-236.
13. Xu DL, Liu Y, Tan J-M, et al,. Marked prolongation of murine cardiac allograft survival using recipient immature dendritic cells loaded with donor-derived apoptotic cells. Scand J Immunol 2004; 59: 536-544.
14. Turnquist HR, Raimondi G, Zahorchak AF, Fischer RT, Wang Z, Thomson AW,. Rapamycin-conditioned dendritic cells are poor stimulators of allogeneic CD4+ T cells, but enrich for antigen-specific Foxp3 +T regulatory cells and promote organ transplant tolerance. J Immunol 2007; 178: 7018-7031.
15. Mirenda V, Berton I, Read J, et al,. Modified dendritic cells coexpressing self and allogeneic major histocompatibility complex molecules: An efficient way to induce indirect pathway regulation. J Am Soc Nephrol 2004; 15: 987-997.
16. Sato K, Yamashita N, Yamashita N, Baba M, Matsuyama T,. Regulatory dendritic cells protect mice from murine acute graft-versus-host disease and leukemia relapse. Immunity 2003; 18: 367-379.
17. Divito JS,., Wang Z, Shufesky WJ, et al,. Endogenous dendritic cells mediate the effects of intravenous injected therapeutic immunosuppressive dendritic cells in transplantation. Blood 2010; 116: 2694-2705.
18. Inaba K, Turley S, Yamaide F, et al,. Efficient presentation of phagocytosed cellular fragments on the major histocompatibiliy complex class II products of dendritic cells. J Exp Med 1998; 188: 2163-2173.
19. Bedford P, Gardner K, Knight SC,. MHC class II molecules transferred between allogeneic dendritic cells stimulate primary lymphocyte reactions. Int Immunol 1999; 11: 1739-1744.
20. Russo V, Zhou D, Sartirana P, et al,. Acquisition of intact allogeneic human leukocyte antigen molecules by human dendritic cells. Blood 2000; 95: 3473.
21. Harshyne LA, Watkins SC, Gambotto A, Barratt-Boyes SM,. Dendritic cells acquire antigens from live cells for cross-presentation to CTL. J Immunol 2001; 166: 3717-3723.
22. Barroso Herrera O, Golshayan D, Tibbott R, et al,. A novel pathway of alloantigen presentation by dendritic cells. J Immunol 2004; 173: 4828-4837.
23. + T-cell activation after viral infection. Nature 2011; 471: 629-632.
24. Watkins SC, Salter RD,. Functional connectivity between immune cells mediated by tunneling nanotubules. Immunity 2005; 23: 309-318.
25. Albert ML, Sauter B, Bhardwaj N,. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 1998; 392: 86-89.
26. Montecalvo A, Shufesky WJ, Beer Stolz D, et al,. Exosomes as a short-range mechanism to spread alloantigen between dendritic cells during T-cell allorecognition. J Immunol 2008; 180: 3081-3090.
27. Yu G, Xu X, Vu MD, Kilpatrick ED, Li XC,. NK cells promote transplant tolerance by killing donor antigen-presenting cells. J Exp Med 2006; 203: 1851-1858.
28. Laffont S, Seillet C, Ortaldo J, Coudert JD, Guery J-C,. Natural killer cells recruited into lymph nodes inhibit alloreactive T-cell activation through perforin-mediated killing of donor allogeneic dendritic cells. Blood 2008; 112: 661-671.
29. Laffont S, Coudert JD, Garidou L,. CD8+ T-cell-mediated killing of donor dendritic cells prevents alloreactive T helper type 2 responses in vivo. Blood 2006; 108: 2257-2264.
30. + T cells. J Immunol 2005; 175: 6428-6435.
31. Jung S, Unutmaz D, Wong P, et al,. In vivo depletion of CD11 c +dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens. Immunity 2002; 17: 211-220.
32. +, T cells by plasmacytoid dendritic cells. J Exp Med 2007; 204: 1923-1933.
33. Zheng XX, Sayegh MH, Zheng X-G, et al,. The role of donor and recipient B7-1 (CD80) in allograft rejection. J Immunol 1997; 159: 1169-1173.
34. Mandelbrot DA, Furukawa Y, McAdam AJ, et al,. Expression of B7 molecules in recipient, not donor, mice determines the survival of cardiac allografts. J Immunol 1999; 163: 3753-3757.
35. Garrod KR, Liu F-C, Forrest LE, Parker I, Kang S-M, Cahalan MD,. NK cell patrolling and elimination of donor-derived dendritic cells favor indirect alloreactivity. J Immunol 2010; 184: 2329-2336.
36. Hawiger D, Inaba K, Dorsett Y, et al,. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J Exp Med 2001; 194: 769-779.
37. Bonifaz L, Bonnyay D, Mahnke K, Rivera M, Nussenzweig MC, Steinman RM,. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. J Exp Med 2002; 196: 1627-1638.
38. + regulatory T cells by targeting of antigens to immature dendritic cells. Blood 2003; 101: 4862-4869.
39. Wang Z, Larregina AT, Shufesky WJ, et al,. Use of the inhibitory effect of apoptotic cells on dendritic cells for graft survival via T-cell deletion and regulatory T cells. Am J Transplant 2006; 6: 1297-1311.
40. Wang Z, Shufesky WJ, Montecalvo A, Divito SJ, Larregina AT, Morelli AE,. In situ-targeting of dendritic cells with donor-derived apoptotic cells restrains indirect allorecognition and ameliorates allograft vasculopathy. PLoS ONE 2009; 4: e4940.
41. Tanriver Y, Ratnasothy K, Bucy RP, Lombardi G, Lechler R,. Targeting MHC class I monomers to dendritic cells inhibits the indirect pathway of allorecognition and the production of IgG alloantibodies leading to long-term allograft survival. J Immunol 2010; 184: 1757-1764.
42. Lee RS, Grusby MJ, Glimcher LH, Winn HJ, Auchincloss H Jr,. Indirect recognition by helper cells can induce donor-specific cytotoxic T lymphocytes in vivo. J Exp Med 1994; 179: 865-872.
43. Chen Y, Demir Y, Valujskikh A, Heeger PS,. The male minor transplantation antigen preferentially activates recipient CD4+ T cells through the indirect presentation pathway in vivo. J Immunol 2003; 171: 6510-6518.
44. Brennan TV, Jaigirdar A, Hoang V, et al,. Preferential priming of alloreactive T cells with indirect reactivity. Am J Transplant 2009; 9: 709-718.
45. Yamada A, Chandraker A, Laufer TM, Gerth AJ, Sayegh MH, Auchincloss H Jr,. Recipient MHC class II expression is required to achieve long-term survival of murine cardiac allografts after costimulatory blockade. J Immunol 2001; 167: 5522-5526.
46. Kleindienst P, Brocker T,. Endogenous dendritic cells are required for amplification of T cell responses induced by dendritic cell vaccines in vivo. J Immunol 2003; 170: 2817-2823.
47. Quezada SA, Fuller B, Jarvinen LZ, et al,. Mechanisms of donor-specific transfusion tolerance: Preemptive induction of clonal T-cell exhaustion via indirect presentation. Blood 2003; 102: 1920-1926.
48. Kishimoto K, Yuan X, Auchincloss H, Sharpe AH, Mandelbrot DA, Sayegh MH,. Mechanisms of action of donor-specific transfusion in inducing tolerance: Role of donor MHC molecules, donor co-stimulatory molecules, and indirect antigen presentation. J Am Soc Nephrol 2004; 15: 2423-2428.